Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Bioteknik
|
33K |
16M |
0 |
26/05/21 |
26/05/21 |
Charts
|
33K
|
16M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Bioteknik
|
25K |
12M |
4 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
25K
|
12M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Bioteknik
|
25K |
12M |
8 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
25K
|
12M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
KEEP IMU AUSTRALIAN OWNED
|
|
Bioteknik
|
135 |
66K |
11 |
15/05/21 |
15/05/21 |
ASX - By Stock
|
135
|
66K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Bioteknik
|
25K |
12M |
10 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
25K
|
12M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Bioteknik
|
25K |
12M |
42 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
25K
|
12M
|
42
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Bioteknik
|
274 |
76K |
3 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
274
|
76K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Bioteknik
|
274 |
76K |
2 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
274
|
76K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Bioteknik
|
13 |
4.7K |
3 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
13
|
4.7K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces $5.55m capital raising
|
|
Bioteknik
|
149 |
44K |
20 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
149
|
44K
|
20
|
|
ASX - By Stock
|
CYP |
Re:
Foreign Interest
|
|
Bioteknik
|
16 |
3.9K |
12 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
16
|
3.9K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
Bioteknik
|
507 |
1.5M |
8 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
507
|
1.5M
|
8
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
Bioteknik
|
507 |
1.5M |
23 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
507
|
1.5M
|
23
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Receipt of notice under section 249N of the Corporations Act
|
|
Bioteknik
|
99 |
42K |
12 |
15/10/19 |
15/10/19 |
ASX - By Stock
|
99
|
42K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Fujifilm Exercises License Option in GvHD
|
|
Bioteknik
|
327 |
127K |
21 |
02/10/19 |
02/10/19 |
ASX - By Stock
|
327
|
127K
|
21
|
|
ASX - By Stock
|
CYP |
Re:
CYP Trading - post Fuji validation
|
|
Bioteknik
|
221 |
81K |
15 |
20/09/19 |
20/09/19 |
ASX - By Stock
|
221
|
81K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
Bioteknik
|
97 |
41K |
11 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
97
|
41K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
Bioteknik
|
97 |
41K |
21 |
13/09/19 |
13/09/19 |
ASX - By Stock
|
97
|
41K
|
21
|
|
ASX - By Stock
|
CYP |
Re:
Fair Value Please
|
|
Bioteknik
|
469 |
232K |
12 |
12/09/19 |
12/09/19 |
ASX - By Stock
|
469
|
232K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Bioteknik
|
4.4K |
2.4M |
23 |
11/09/19 |
11/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
23
|
|
ASX - By Stock
|
CYP |
Re:
Fair Value Please
|
|
Bioteknik
|
469 |
232K |
28 |
20/07/19 |
20/07/19 |
ASX - By Stock
|
469
|
232K
|
28
|
|
ASX - By Stock
|
CYP |
Re:
Fuji
|
|
Bioteknik
|
80 |
27K |
24 |
14/07/19 |
14/07/19 |
ASX - By Stock
|
80
|
27K
|
24
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
Bioteknik
|
2.1K |
697K |
15 |
03/07/19 |
03/07/19 |
ASX - By Stock
|
2.1K
|
697K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Extends FUJIFILM Licence Option in GvHD
|
|
Bioteknik
|
258 |
86K |
15 |
25/03/19 |
25/03/19 |
ASX - By Stock
|
258
|
86K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Extends FUJIFILM Licence Option in GvHD
|
|
Bioteknik
|
258 |
86K |
17 |
22/03/19 |
22/03/19 |
ASX - By Stock
|
258
|
86K
|
17
|
|
ASX - By Stock
|
CYP |
Re:
deal
|
|
Bioteknik
|
99 |
51K |
8 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
99
|
51K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
deal
|
|
Bioteknik
|
99 |
51K |
9 |
20/03/19 |
20/03/19 |
ASX - By Stock
|
99
|
51K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
Bioteknik
|
2.1K |
697K |
6 |
26/02/19 |
26/02/19 |
ASX - By Stock
|
2.1K
|
697K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Just for fun
|
|
Bioteknik
|
26 |
10K |
6 |
20/12/18 |
20/12/18 |
ASX - By Stock
|
26
|
10K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Vinegar strokes
|
|
Bioteknik
|
5 |
3.2K |
4 |
19/10/18 |
19/10/18 |
ASX - By Stock
|
5
|
3.2K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Results of Meeitng
|
|
Bioteknik
|
32 |
12K |
18 |
12/09/18 |
12/09/18 |
ASX - By Stock
|
32
|
12K
|
18
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata GvHD Trial Meets all Safety & Efficacy Endpoints
|
|
Bioteknik
|
61 |
25K |
13 |
31/08/18 |
31/08/18 |
ASX - By Stock
|
61
|
25K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata GvHD Trial Meets all Safety & Efficacy Endpoints
|
|
Bioteknik
|
61 |
25K |
23 |
31/08/18 |
31/08/18 |
ASX - By Stock
|
61
|
25K
|
23
|
|
ASX - By Stock
|
CYP |
Re:
A No voting block & an alternative loan facility
|
|
Bioteknik
|
266 |
94K |
5 |
21/08/18 |
21/08/18 |
ASX - By Stock
|
266
|
94K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Bioteknik
|
154 |
60K |
3 |
13/08/18 |
13/08/18 |
ASX - By Stock
|
154
|
60K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3B-Exercise of Options
|
|
Bioteknik
|
5 |
4.2K |
10 |
12/07/18 |
12/07/18 |
ASX - By Stock
|
5
|
4.2K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD
|
|
Bioteknik
|
37 |
15K |
3 |
15/06/18 |
15/06/18 |
ASX - By Stock
|
37
|
15K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
Bioteknik
|
75 |
48K |
2 |
31/05/18 |
31/05/18 |
ASX - By Stock
|
75
|
48K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
We are close
|
|
Bioteknik
|
53 |
19K |
4 |
20/05/18 |
20/05/18 |
ASX - By Stock
|
53
|
19K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
We are close
|
|
Bioteknik
|
53 |
19K |
2 |
20/05/18 |
20/05/18 |
ASX - By Stock
|
53
|
19K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
We are close
|
|
Bioteknik
|
53 |
19K |
15 |
20/05/18 |
20/05/18 |
ASX - By Stock
|
53
|
19K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
cell & gene investor day
|
|
Bioteknik
|
13 |
5.7K |
3 |
28/04/18 |
28/04/18 |
ASX - By Stock
|
13
|
5.7K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: CYP Completes Patent Application related to CAR-T Therapy
|
|
Bioteknik
|
66 |
22K |
10 |
20/04/18 |
20/04/18 |
ASX - By Stock
|
66
|
22K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Valuation $3.71 today, increasing to $9 + plus corporate activity
|
|
Bioteknik
|
67 |
27K |
12 |
18/03/18 |
18/03/18 |
ASX - By Stock
|
67
|
27K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Stephen Hawkin
|
|
Bioteknik
|
4 |
1.3K |
7 |
15/03/18 |
15/03/18 |
ASX - By Stock
|
4
|
1.3K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3B-Exercise of Options
|
|
Bioteknik
|
18 |
7.4K |
21 |
28/02/18 |
28/02/18 |
ASX - By Stock
|
18
|
7.4K
|
21
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Final Preclinical Asthma Study Confirms Efficacy
|
|
Bioteknik
|
40 |
12K |
7 |
12/12/17 |
12/12/17 |
ASX - By Stock
|
40
|
12K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Phase 1 interim results imminent
|
|
Bioteknik
|
95 |
23K |
7 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
95
|
23K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata to Increase Exposure in Japan
|
|
Bioteknik
|
80 |
23K |
6 |
12/10/17 |
12/10/17 |
ASX - By Stock
|
80
|
23K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
got to pay to play now .80+ soon
|
|
Bioteknik
|
49 |
10K |
11 |
19/09/17 |
19/09/17 |
ASX - By Stock
|
49
|
10K
|
11
|
|